Large-scale diagnostic testing remains at the heart of global efforts to confront the spread of the SARS-CoV-2 coronavirus.
The availability of rapid and reliable diagnostic tests for COVID-19 has proven critical during the pandemic, reducing onward infections through contact tracing measures. The early identification of positive cases has been particularly important given the significant contribution of asymptomatic transmission to overall rates of infection. Despite the impressive pace of national vaccination programs in recent months, concerns over the emergence of more vaccine-resistant variants mean diagnostic testing will continue to be a major part of the long-term strategy for pandemic management.
Read more on Labcompare.